Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

Forty percent of non-small cell lung cancer (NSCLC) patients develop brain metastases, resulting in a dismal prognosis. However, patients in an oligo-metastatic brain disease setting seem to have better outcomes. Here, we investigate the possibility of using circulating tumor cells (CTCs) as biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanssen, Annkathrin, Riebensahm, Carlotta, Mohme, Malte, Joosse, Simon A., Velthaus, Janna-Lisa, Berger, Lars Arne, Bernreuther, Christian, Glatzel, Markus, Loges, Sonja, Lamszus, Katrin, Westphal, Manfred, Riethdorf, Sabine, Pantel, Klaus, Wikman, Harriet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315958/
https://www.ncbi.nlm.nih.gov/pubmed/30572662
http://dx.doi.org/10.3390/cancers10120527

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315958/
https://www.ncbi.nlm.nih.gov/pubmed/30572662
http://dx.doi.org/10.3390/cancers10120527

Ejemplares similares